HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Malek G. Massad Alexander S. Geha Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shuhaiber, J. H. Articles by Geha, A. S. Search for Related Content PubMed PubMed Citation Articles by Shuhaiber, J. H. Articles by Geha, A. S. Related Collections Coronary disease

Eur J Cardiothorac Surg 2002;22:387-396
© 2002 Elsevier Science NL

Review

Mechanisms and future directions for prevention of vein graft failure in coronary bypass surgery

Division of Cardiothoracic Surgery, Department of Surgery, The University of Illinois at Chicago, 840 South Wood Street, CSB Suite 417 (MC 958), Chicago, IL 60612, USA

Received 10 January 2002; received in revised form 21 March 2002; accepted 18 April 2002.

* Corresponding author. Tel.: +1-312-996-6215; fax: +1-312-996-2013
e-mail: mmassad{at}uic.edu

Coronary artery bypass grafting has been utilized as a beneficial treatment for myocardial ischemic disease for over three decades. Failure of coronary artery venous grafts occurs at a substantial rate and has a large impact on two main endpoints, survival and quality of life. An exhaustive amount of basic research has been generated to delineate possible mechanisms responsible for graft failure and modalities to prevent its occurrence. Although pharmacotherapy exists, insufficient translation has emerged from the bench to the operating room. In this article, we review the literature regarding the current mechanisms and mediators including growth factors, nitric oxide and genetics leading to saphenous vein graft occlusion. The review addresses the current state of affairs and modes for prevention of vein graft failure perioperatively and newer technologies that may help ameliorate this problem in the future.

Key Words: Vein graft failure • Mechanisms • Future directions • Prevention • Coronary artery bypass

This article has been cited by other articles:

				M. R. Dashwood, K. Savage, J. C.S. Tsui, A. Dooley, S. G. Shaw, M. S. Fernandez Alfonso, L. Bodin, and D. S.R. Souza Retaining perivascular tissue of human saphenous vein grafts protects against surgical and distension-induced damage and preserves endothelial nitric oxide synthase and nitric oxide synthase activity. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 334 - 340. [Abstract] [Full Text] [PDF]

				P. Narayan, M. Yeatman, M. Caputo, R. Capoun, F. Ciulli, J. Y. Jeremy, and G. D. Angelini Saphenous vein harvest with the Mayo extraluminal dissector: is endothelial function preserved? J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 508 - 510. [Full Text] [PDF]

				H. Song, A. L. Mowbray, M. C. Sykes, and H. Jo Emerging Role of IGF-1R in Stretch-Induced Neointimal Hyperplasia in Venous Grafts Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1679 - 1681. [Full Text] [PDF]

				A. W.Y. Chung, P. Rauniyar, H. Luo, Y. N. Hsiang, C. van Breemen, and E. B. Okon Pharmacologic relaxation of vein grafts is beneficial compared with pressure distention caused by upregulation of endothelial nitric oxide synthase and nitric oxide production J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 925 - 932. [Abstract] [Full Text] [PDF]

				T. Schachner, G. Laufer, and J. Bonatti In vivo (animal) models of vein graft disease. Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 451 - 463. [Abstract] [Full Text] [PDF]

				T. Schachner Pharmacologic inhibition of vein graft neointimal hyperplasia J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1065 - 1072. [Abstract] [Full Text] [PDF]

				T. Walker, H. P. Wendel, L. Tetzloff, O. Heidenreich, and G. Ziemer Suppression of ICAM-1 in human venous endothelial cells by small interfering RNAs Eur. J. Cardiothorac. Surg., December 1, 2005; 28(6): 816 - 820. [Abstract] [Full Text] [PDF]

				V. R. Conti and G. C. Hunter Gene Therapy and Vein Graft Patency in Coronary Artery Bypass Graft Surgery JAMA, November 16, 2005; 294(19): 2495 - 2497. [Full Text] [PDF]

				M. R. Dashwood, K. Savage, A. Dooley, X. Shi-Wen, D. J. Abraham, and D. S.R. Souza Effect of Vein Graft Harvesting on Endothelial Nitric Oxide Synthase and Nitric Oxide Production Ann. Thorac. Surg., September 1, 2005; 80(3): 939 - 944. [Abstract] [Full Text] [PDF]

				P. J. Shah, I. Gordon, J. Fuller, S. Seevanayagam, A. Rosalion, J. Tatoulis, J. S. Raman, and B. F. Buxton Factors affecting saphenous vein graft patency: clinical and angiographic study in 1402 symptomatic patients operated on between 1977 and 1999 J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1972 - 1977. [Abstract] [Full Text] [PDF]

				V. R. Conti and G. C. Hunter Gene Therapy and Vein Graft Patency in Coronary Artery Bypass Graft Surgery JAMA, November 16, 2005; 294(19): 2495 - 2497. [Full Text] [PDF]